Alnylam Pharmaceuticals reported $523.65M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 182.55M 20.97M
Agios Pharmaceuticals AGIO:US USD -24371000 114.53M
Alnylam Pharmaceuticals ALNY:US USD 523.65M 75.28M
Amgen AMGN:US USD 4.61B 695M
Arrowhead Research ARWR:US USD 104.68M 10.72M
Avrobio Inc AVRO:US USD 25.26M 2.27M
Biocryst Pharmaceuticals BCRX:US USD 125.86M 32.58M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
Mirati Therapeutics MRTX:US USD 212.66M 20.78M
Moderna Inc MRNA:US USD 3.5B 1.31B
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Novartis NVS:US USD 11.05B 378M
Ptc Therapeutics PTCT:US USD 367.75M 82.44M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Regulus Therapeutics RGLS:US USD 6.93M 631K
Sangamo Biosciences SGMO:US USD 82.62M 1.27M
Sarepta Therapeutics SRPT:US USD 367.84M 119.23M
Takeda 4502:JP JPY 949.56B 51.69B
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M
Xencor XNCR:US USD 64.3M 1.34M
YTE INCY:US USD 856.61M 171.68M